(CercleFinance.com) – Rather encouraged by the strength displayed by Wall Street the day before, the European stock markets posted more or less pronounced gains (+0.5% in London, +0.2% in Paris and Frankfurt) this Wednesday after the long Christmas weekend.
Investor morale in this shortened week of confectioners’ truce seems to continue to be supported by expectations of easing of monetary policies next year, against a backdrop of continued slowdown in inflation.
‘The difficulties in supply chains and high energy prices ended in 2023’, underlines SwissLife AM, for which ‘the double-digit inflation rates sometimes observed in Europe will join the books of history as anomalies’.
‘The weak economic situation should therefore contribute to bringing inflation down to around 2% at the end of 2024 in the euro zone and in Switzerland, i.e. a figure falling within the ‘comfort zone’ of central banks’, continues the Swiss management company .
On the value side, AstraZeneca gained more than 1% in London, after an agreement to acquire Gracell Biotechnologies, a company which develops innovative cell therapies for the treatment of cancer and autoimmune diseases.
In Paris, Orpea climbs by more than 9% while the shareholders of the Ehpads group approved on Friday the appointment of a new board of directors following the arrival in the capital of Caisse des Dépôts, CNP, MAIF and MACSF.
Copyright (c) 2023 CercleFinance.com. All rights reserved.